You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)

Small Molecule Drugs cited in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC

Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)

Date Filed Document No. Description Snippet Link To Document
2021-05-12 1 Complaint United States Patent Nos. 8,731,963 (the “’963 patent”), 10,758,488 (the “’488 patent”), 10,813,885 … for patent infringement and for a declaratory judgement of patent infringement under the patent laws…PageID #: 2 (the “’956 patent”), and 10,966,931 (the “’931 patent”) owned by Jazz Pharmaceuticals (…’963 patent entitled, “Sensitive Drug Distribution System and Method.” A copy of the ’963 patent is attached…of the ’931 patent is attached hereto as Exhibit E. 27. The claims of the patents-in-suit cover External link to document
2021-06-03 11 Answer to Complaint United States Patent Nos. 8,731,963 (the “’963 patent”), 10,758,488 (the “’488 patent”), 10,813,885 (…United States Patent Nos. 8,731,963 (the “’963 patent”), 10,758,488 (the “’488 patent”), 10,813,885 (… for patent infringement and for a declaratory judgement of patent infringement under the patent laws … (the “’885 patent”), 10,959,956 (the “’956 patent”), and 10,966,931 (the “’931 patent”) owned by Jazz… for patent infringement and for a declaratory judgment of patent infringement under the patent laws External link to document
2022-06-23 117 Motion for Judgment on the Pleadings counterclaim seeking delisting of U.S. Patent No. 8,731,963 (the “’963 patent”) from the Orange Book (see D.I…submit a request to the FDA to delist the ’963 patent pursuant to 21 U.S.C. § 355(c)(3)(D)(ii)(I). The… 12 May 2021 1:21-cv-00691 830 Patent None District Court, D. Delaware External link to document
2022-06-23 118 Opening Brief in Support seeking delisting of Jazz’s U.S. Patent No. 8,731,963 (the “’963 patent”) from the FDA’s Orange Book.1 …the FDA “the patent number and expiration date of each patent for which a claim of patent infringement…Orange Book-listed patents for XYREM. D.I. 1, Exhibit F at 163. Of the seven patents Jazz has accused …only the ’963 patent is listed in the Orange Book and therefore is the only asserted patent that could …26, and 27 of the ’963 Patent, along with all claims of six other issued patents in the family. Only claims External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.